Baxter makes hospital basics — IV fluids, pumps and kidney care products.
Baxter International Inc. (BAX) is expected to report earnings on Thursday, October 29, 2026, after the close. Estimated release time 07:17 ET. Consensus EPS estimate is $0.51.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-07-30 | FY2026 Q2 | $0.37 | $0.56 | +52.8% | $2.96B |
| 2026-04-30 | FY2026 Q1 | $0.31 | $0.36 | +15.8% | $2.70B |
| 2025-10-30 | FY2025 Q3 | $0.60 | $0.69 | +15.0% | $2.83B |
| 2025-07-31 | FY2025 Q2 | $0.60 | $0.59 | -1.7% | $2.81B |
| 2025-05-01 | FY2025 Q1 | $0.48 | $0.55 | +13.8% | $2.62B |
| 2025-02-21 | FY2024 Q4 | $0.53 | $0.58 | +9.8% | $2.75B |
| 2024-11-08 | FY2024 Q3 | $0.78 | $0.49 | -37.2% | $2.70B |
| 2024-08-06 | FY2024 Q2 | $0.66 | $0.68 | +2.7% | $2.69B |
BAX has beaten consensus EPS in 6 of its last 8 reported quarters.
BAX reported Jul 30. The highlights: EPS of $0.56 — a big beat vs the $0.37 estimate (+53%); revenue of $2.96B — a beat vs the $2.80B consensus (+6%). Focus now shifts to margins and portfolio simplification.
BAX pays a quarterly dividend, currently yielding 0.15%.
| Ex-dividend date | Amount | Paid |
|---|---|---|
| 2026-08-28 | $0.01 | 2026-10-01 |
| 2026-05-29 | $0.01 | 2026-07-01 |
| 2026-02-27 | $0.01 | 2026-04-01 |
| 2025-11-28 | $0.01 | 2026-01-02 |
| 2025-08-29 | $0.17 | 2025-10-01 |
| 2025-05-30 | $0.17 | 2025-07-01 |